Literature DB >> 17131147

Anticoagulant heparan sulfate: structural specificity and biosynthesis.

Jian Liu1, Lars C Pedersen.   

Abstract

Heparan sulfate (HS) is present on the surface of endothelial and surrounding tissues in large quantities. It plays important roles in regulating numerous functions of the blood vessel wall, including blood coagulation, inflammation response, and cell differentiation. HS is a highly sulfated polysaccharide containing glucosamine and glucuronic/iduronic acid repeating disaccharide units. The unique sulfated saccharide sequences of HS determine its specific functions. Heparin, an analog of HS, is the most commonly used anticoagulant drug. Because of its wide range of biological functions, HS has become an interesting molecule to biochemists, medicinal chemists, and developmental biologists. In this review, we summarize recent progress toward understanding the interaction between HS and blood-coagulating factors, the biosynthesis of anticoagulant HS and the mechanism of action of HS biosynthetic enzymes. Furthermore, knowledge of the biosynthesis of HS facilitates the development of novel enzymatic approaches to synthesize HS from bacterial capsular polysaccharides and to produce polysaccharide end products with high specificity for the biological target. These advancements provide the foundation for the development of polysaccharide-based therapeutic agents.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17131147      PMCID: PMC1876722          DOI: 10.1007/s00253-006-0722-x

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  57 in total

1.  Purification of heparan sulfate D-glucosaminyl 3-O-sulfotransferase.

Authors:  J Liu; N W Shworak; L M Fritze; J M Edelberg; R D Rosenberg
Journal:  J Biol Chem       Date:  1996-10-25       Impact factor: 5.157

Review 2.  Heparin-induced thrombocytopenia: an overview.

Authors:  J G Kelton
Journal:  Blood Rev       Date:  2002-03       Impact factor: 8.250

3.  A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry.

Authors:  D Shukla; J Liu; P Blaiklock; N W Shworak; X Bai; J D Esko; G H Cohen; R J Eisenberg; R D Rosenberg; P G Spear
Journal:  Cell       Date:  1999-10-01       Impact factor: 41.582

4.  Multiple isozymes of heparan sulfate/heparin GlcNAc N-deacetylase/GlcN N-sulfotransferase. Structure and activity of the fourth member, NDST4.

Authors:  J Aikawa ; K Grobe; M Tsujimoto; J D Esko
Journal:  J Biol Chem       Date:  2000-11-21       Impact factor: 5.157

5.  Expression of heparan sulfate D-glucosaminyl 3-O-sulfotransferase isoforms reveals novel substrate specificities.

Authors:  J Liu; N W Shworak; P Sinaÿ; J J Schwartz; L Zhang; L M Fritze; R D Rosenberg
Journal:  J Biol Chem       Date:  1999-02-19       Impact factor: 5.157

6.  The ternary complex of antithrombin-anhydrothrombin-heparin reveals the basis of inhibitor specificity.

Authors:  Alexey Dementiev; Maurice Petitou; Jean-Marc Herbert; Peter G W Gettins
Journal:  Nat Struct Mol Biol       Date:  2004-08-15       Impact factor: 15.369

7.  Contribution of monosaccharide residues in heparin binding to antithrombin III.

Authors:  D H Atha; J C Lormeau; M Petitou; R D Rosenberg; J Choay
Journal:  Biochemistry       Date:  1985-11-05       Impact factor: 3.162

8.  13C-NMR relation study of heparin-disaccharide interactions with tripeptides GRG and GKG.

Authors:  D Mikhailov; K H Mayo; A Pervin; R J Linhardt
Journal:  Biochem J       Date:  1996-04-15       Impact factor: 3.857

9.  Biosynthesis of 3-O-sulfated heparan sulfate: unique substrate specificity of heparan sulfate 3-O-sulfotransferase isoform 5.

Authors:  Jinghua Chen; Michael B Duncan; Kevin Carrick; R Marshall Pope; Jian Liu
Journal:  Glycobiology       Date:  2003-08-07       Impact factor: 4.313

10.  Structure of the antithrombin-thrombin-heparin ternary complex reveals the antithrombotic mechanism of heparin.

Authors:  Wei Li; Daniel J D Johnson; Charles T Esmon; James A Huntington
Journal:  Nat Struct Mol Biol       Date:  2004-08-15       Impact factor: 15.369

View more
  44 in total

1.  Screening for anticoagulant heparan sulfate octasaccharides and fine structure characterization using tandem mass spectrometry.

Authors:  Hicham Naimy; Nancy Leymarie; Joseph Zaia
Journal:  Biochemistry       Date:  2010-05-04       Impact factor: 3.162

2.  Chemoenzymatic design of heparan sulfate oligosaccharides.

Authors:  Renpeng Liu; Yongmei Xu; Miao Chen; Michel Weïwer; Xianxuan Zhou; Arlene S Bridges; Paul L DeAngelis; Qisheng Zhang; Robert J Linhardt; Jian Liu
Journal:  J Biol Chem       Date:  2010-08-21       Impact factor: 5.157

3.  Temporal and functional changes in glycosaminoglycan expression during osteogenesis.

Authors:  Victor Nurcombe; Fuqi Jack Goh; Larisa M Haupt; Sadasivam Murali; Simon M Cool
Journal:  J Mol Histol       Date:  2007-08-03       Impact factor: 2.611

4.  Structure Activity Relationship of Heparin Mimicking Polymer p(SS-co-PEGMA): Effect of Sulfonation and Polymer Size on FGF2-Receptor Binding.

Authors:  Samantha J Paluck; Heather D Maynard
Journal:  Polym Chem       Date:  2017-07-05       Impact factor: 5.582

5.  Perlecan domain I gradients establish stable biomimetic heparin binding growth factor gradients for cell migration in hydrogels.

Authors:  Kelsea M Hubka; Daniel D Carson; Daniel A Harrington; Mary C Farach-Carson
Journal:  Acta Biomater       Date:  2019-07-24       Impact factor: 8.947

6.  Cloning and Characterization of a Chondroitin AC Exolyase from Arthrobacter sp. SD-04.

Authors:  Lu-Zhou Chen; Chu-Qi Shi; Feng-Xin Yin; Feng-Shan Wang; Ju-Zheng Sheng
Journal:  Mol Biotechnol       Date:  2019-10       Impact factor: 2.695

7.  Synthesis of 3-O-Sulfated Oligosaccharides to Understand the Relationship between Structures and Functions of Heparan Sulfate.

Authors:  Zhangjie Wang; Po-Hung Hsieh; Yongmei Xu; David Thieker; Evangeline Juan En Chai; Shaoshuai Xie; Brian Cooley; Robert J Woods; Lianli Chi; Jian Liu
Journal:  J Am Chem Soc       Date:  2017-04-03       Impact factor: 15.419

8.  Using a 3-O-sulfated heparin octasaccharide to inhibit the entry of herpes simplex virus type 1.

Authors:  Ronald Copeland; Arun Balasubramaniam; Vaibhav Tiwari; Fuming Zhang; Arlene Bridges; Robert J Linhardt; Deepak Shukla; Jian Liu
Journal:  Biochemistry       Date:  2008-05-06       Impact factor: 3.162

9.  Hs3st3-modified heparan sulfate controls KIT+ progenitor expansion by regulating 3-O-sulfotransferases.

Authors:  Vaishali N Patel; Isabelle M A Lombaert; Samuel N Cowherd; Nicholas W Shworak; Yongmei Xu; Jian Liu; Matthew P Hoffman
Journal:  Dev Cell       Date:  2014-06-23       Impact factor: 12.270

Review 10.  Heparan sulfate 3-O-sulfation: a rare modification in search of a function.

Authors:  Bryan E Thacker; Ding Xu; Roger Lawrence; Jeffrey D Esko
Journal:  Matrix Biol       Date:  2013-12-19       Impact factor: 11.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.